治疗老年和脆弱骨髓瘤患者的治疗方法
Steven Chun-Min Shih1, Alissa Visram2, Hira Mian3
1Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
概括
患有多发性骨髓瘤 (MM) 的老年人因衰老和疾病复杂性而面临治疗挑战. 本综述强调了新型疗法和脆弱性评估,以改善老年MM患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 老年病的医生 老年病的医生
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 患病率在老年人中正在上升,这带来了独特的治疗挑战.
- 衰老和疾病异质性使老年MM患者的治疗策略复杂化.
- 最近的进展包括免疫调节药物,蛋白酶体抑制剂和抗CD38抗体在MM治疗中.
研究的目的:
- 审查老年和脆弱的多发性骨髓瘤患者当前和未来的治疗策略.
- 强调脆弱性评估在指导MM的老年人治疗决策中的重要性.
- 确定知识差距,并建议未来的研究方向,以改善这一人口中的MM结果.
主要方法:
- 文献综述,重点关注老年和脆弱多发性骨髓瘤患者的治疗.
- 对MM的新疗法 (包括免疫疗法) 的分析.
- 讨论有关MM的老年人风险分层和支持性护理.
主要成果:
- 在过去的二十年中,新型治疗方法显著改善了MM的老年患者的治疗结果.
- 免疫疗法,包括T细胞参与剂和CAR T细胞疗法,对未来的MM治疗有希望.
- 脆弱性评估对于优化老年MM患者治疗至关重要.
结论:
- 在老年人中优化MM治疗需要平衡新疗法与患者的脆弱性.
- 未来的研究应该专注于个性化治疗方法,并解决老年MM护理当前的知识差距.
- 免疫疗法和支持性护理的持续进步预计将进一步改善MM的老年人的治疗结果.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


